Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With
Epidermal growth factor receptor
Guidelines
Non–small cell lung cancer
Systematic review
Journal
JTO clinical and research reports
ISSN: 2666-3643
Titre abrégé: JTO Clin Res Rep
Pays: United States
ID NLM: 101769967
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
06
10
2020
accepted:
07
10
2020
entrez:
30
9
2021
pubmed:
1
10
2021
medline:
1
10
2021
Statut:
epublish
Résumé
Patients with NSCLC in East Asia, including Japan, frequently contain
Identifiants
pubmed: 34589972
doi: 10.1016/j.jtocrr.2020.100107
pii: S2666-3643(20)30153-3
pmc: PMC8474490
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100107Informations de copyright
© 2020 The Authors.
Références
Int J Clin Oncol. 2019 Jul;24(7):731-770
pubmed: 31049758
J Clin Oncol. 2018 Aug 1;36(22):2244-2250
pubmed: 29864379
Lung Cancer. 2019 Jul;133:23-31
pubmed: 31200823
J Clin Oncol. 2009 Mar 20;27(9):1394-400
pubmed: 19224850
Ann Oncol. 2019 Dec 1;30(12):1978-1984
pubmed: 31553438
N Engl J Med. 2009 Sep 3;361(10):958-67
pubmed: 19692684
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Lancet Oncol. 2019 Jul;20(7):924-937
pubmed: 31122901
Ann Oncol. 2014 Aug;25(8):1475-84
pubmed: 24669016
Patient. 2018 Feb;11(1):131-141
pubmed: 29178024
Clin Cancer Res. 2016 Sep 15;22(18):4585-93
pubmed: 27225694
Jpn J Clin Oncol. 2016 May;46(5):462-7
pubmed: 26977054
Lancet Respir Med. 2019 May;7(5):387-401
pubmed: 30922878
Lancet Oncol. 2016 May;17(5):577-89
pubmed: 27083334
Lancet Oncol. 2017 Nov;18(11):1454-1466
pubmed: 28958502
Ann Oncol. 2014 Jan;25(1):126-31
pubmed: 24285021
JAMA Oncol. 2019 Oct 1;5(10):1448-1455
pubmed: 31393548
Lung Cancer. 2018 Jul;121:5-11
pubmed: 29858027
Ann Oncol. 2015 Sep;26(9):1877-1883
pubmed: 26141208
Ann Oncol. 2013 Jan;24(1):54-9
pubmed: 22967997
N Engl J Med. 2010 Jun 24;362(25):2380-8
pubmed: 20573926
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
J Clin Oncol. 2018 Mar 20;36(9):841-849
pubmed: 28841389
J Clin Oncol. 2013 Sep 20;31(27):3327-34
pubmed: 23816960
Lancet Oncol. 2015 Jul;16(7):830-8
pubmed: 26051236
Lancet Oncol. 2011 Aug;12(8):735-42
pubmed: 21783417
N Engl J Med. 2020 Jan 2;382(1):41-50
pubmed: 31751012
Lancet Oncol. 2010 Feb;11(2):121-8
pubmed: 20022809
Lancet Oncol. 2012 Jan;13(1):e23-31
pubmed: 21764376
J Thorac Oncol. 2012 Sep;7(9):1417-22
pubmed: 22895139
J Clin Oncol. 2020 Jan 10;38(2):124-136
pubmed: 31411950
Lancet Oncol. 2019 Dec;20(12):1655-1669
pubmed: 31591063
Ann Oncol. 2015 Sep;26(9):1883-1889
pubmed: 26105600
Ann Oncol. 2019 Feb 1;30(2):171-210
pubmed: 30596843
BMJ. 2008 Jul 31;337:a744
pubmed: 18669566
Br J Cancer. 2017 Feb 28;116(5):568-574
pubmed: 28103612
Lancet Oncol. 2014 Feb;15(2):213-22
pubmed: 24439929
Lancet Oncol. 2019 May;20(5):625-635
pubmed: 30975627
J Clin Oncol. 2006 Jun 1;24(16):2549-56
pubmed: 16735708
Oncologist. 2012;17(6):863-70
pubmed: 22581822
Lancet Oncol. 2014 Oct;15(11):1236-44
pubmed: 25175099
Am J Respir Crit Care Med. 2008 Jun 15;177(12):1348-57
pubmed: 18337594
JAMA Oncol. 2019 Nov 1;5(11):e192553
pubmed: 31486833
J Clin Oncol. 2020 Jan 10;38(2):115-123
pubmed: 31682542
Clin Cancer Res. 2011 Jun 1;17(11):3812-21
pubmed: 21531810
J Clin Oncol. 2020 Feb 10;38(5):488-495
pubmed: 31825714
Ann Oncol. 2017 Oct 1;28(10):2443-2450
pubmed: 28945850
Lancet Oncol. 2015 Feb;16(2):141-51
pubmed: 25589191
JAMA Oncol. 2018 Feb 1;4(2):210-216
pubmed: 29270615
J Natl Compr Canc Netw. 2019 Dec;17(12):1464-1472
pubmed: 31805526
Lancet Oncol. 2012 Mar;13(3):239-46
pubmed: 22285168